Cantitate/Preț
Produs
Total produse
Vezi coșul
Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1) de M.A. Hayat

Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1): Tumors of the Central Nervous System, cartea 3

Editat de M.A. Hayat
en Limba Engleză Paperback – 15 iul 2013
The classification of brain tumors is up-dated using magnetic resonance spectroscopy technology. The role of cellular immortality in brain tumors is reviewed. Tumor to tumor metastases are a common occurrence; for example, , brain metastasis from breast cancer, lung cancer, and renal cancer is discussed. Genetic profiling and treatment (including neurosurgery) of such brain cancers are explained. Breast cancer patients treated with certain drugs (e.g., capecitabine and lapatinib can develop CNS tumors. Role of brain tumor suppressor genes (e.g., NRP/B gene) is pointed out. Biomarkers used to diagnose brain malignancies are explained in detail. A number of imaging modalities used for diagnosing and assessing the effectiveness of treatments of brain tumors are presented. The imaging methods discussed include MRI, PET, CT,  MRSi, and SPECT.  Also, is discussed the impact of PET using radiolabeled amino acids on brain tumors.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 132505 lei  38-44 zile
  SPRINGER NETHERLANDS – 15 iul 2013 132505 lei  38-44 zile
Hardback (1) 133846 lei  38-44 zile
  SPRINGER NETHERLANDS – 27 mai 2011 133846 lei  38-44 zile

Din seria Tumors of the Central Nervous System

  • 5% Tumors of the Central Nervous System, Volume 14: Glioma, Meningioma, Neuroblastoma, and Spinal Tumors
    Preț: 71465 lei
  • 5% Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
    Preț: 133176 lei
  • 5% Tumors of the Central Nervous System, Volume 10: Pineal, Pituitary, and Spinal Tumors
    Preț: 143249 lei
  • 5% Tumors of the Central Nervous System, Volume 11: Pineal, Pituitary, and Spinal Tumors
    Preț: 111738 lei
  • 5% Tumors of the Central Nervous System, Volume 12: Molecular Mechanisms, Children's Cancer, Treatments, and Radiosurgery
    Preț: 110834 lei
  • 5% Tumors of the Central Nervous System, Volume 13: Types of Tumors, Diagnosis, Ultrasonography, Surgery, Brain Metastasis, and General CNS Diseases
    Preț: 111033 lei
  • 5% Tumors of the Central Nervous System, Volume 2: Gliomas: Glioblastoma (Part 2)
    Preț: 133440 lei
  • 5% Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
    Preț: 132387 lei
  • 5% Tumors of the Central Nervous System, Volume 5: Astrocytomas, Hemangioblastomas, and Gangliogliomas
    Preț: 99561 lei
  • 5% Tumors of the Central Nervous System, Volume 6: Spinal Tumors (Part 1)
    Preț: 109706 lei
  • 5% Tumors of the Central Nervous System, Volume 7: Meningiomas and Schwannomas
    Preț: 141853 lei
  • 5% Tumors of the Central Nervous System, Volume 8: Astrocytoma, Medulloblastoma, Retinoblastoma, Chordoma, Craniopharyngioma, Oligodendroglioma, and Ependymoma
    Preț: 141617 lei
  • 5% Tumors of the Central Nervous System, Volume 9: Lymphoma, Supratentorial Tumors, Glioneuronal Tumors, Gangliogliomas, Neuroblastoma in Adults, Astrocytomas, Ependymomas, Hemangiomas, and Craniopharyngiomas
    Preț: 110850 lei

Preț: 132505 lei

Preț vechi: 139479 lei
-5% Nou

Puncte Express: 1988
Preț estimativ în valută:
25377€ • 26146$ • 21258£

Carte tipărită la comandă

Livrare economică 20-26 februarie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789400736320
ISBN-10: 9400736320
Pagini: 404
Ilustrații: XXII, 382 p.
Dimensiuni: 193 x 260 x 21 mm
Greutate: 0.82 kg
Ediția:2011
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Tumors of the Central Nervous System

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

Preface. Introduction.-1 General introduction.- 2 Brain tumor classification using magnetic resonance spectroscopy.- 3 Cellular immortality in brain tumors: an overview.-Part 1Tumor to tumor passage of malignancy.- 4 Tumor-to-tumor metastases: extracranial tumor metastasis to intracranial  tumors.- 5 Brain metastases from breast cancer: treatment and prognosis.- 6 Brain metastasis in renal cell carcinoma patients.-7 Coexistance of inflammatory myofibroblastic tumors in the lung and brain.- 8 Breast cancer and renal cell cancer metastases to the  brain.-9 Brain metastases from breast cancer: genetic profiling and neurosurgical therapy.-10 Central nervous system tumors in women who received capectiabine and lapatinib therapy for metastatic breast cancer.- Part II Biomarkers and diagnosis.-11 Functional role of the novel nrp/b tumor suppressor gene.-12 Brain tumors:diagnostic impact of pet using radiolabelled amino acids.-13 Malignant peripheral nerve sheath tumors: use of 18fdg-pet/ct.-14 Brain tumors: evaluation of perfusion using 3d-fse-pseudo-continous arterial spin labeling.-15 Cerebral cavernous malformations: advanced magnetic  resonance imaging.-16 Nosologic imaging of brain tumors using mri and mrsi.-17 Brain tumor diagnosis using pet with angiogenic vessel-targeting liposomes.-18 Frozen section evaluation of central nervous system lesions.-19 Clinical role of micrornas in different brain tumors.-Part III Therapy.-20 Electrochemotherapy for primary and secondary brain tumors.-21 Brain tumors: convection-enhanced delivery of drugs (method).- 22 Brain metastases: clinical outcomes for stereotactic radiosurgery (method).-23 Noninvasive treatment for brain tumors:magnetic resonance guided focused ultrasound surgery.-24 Radioguided surgery of brain tumors.-25 Implications of mutant epidermal growth factor variant  III in brain tumor development and novel targeted therapies.-26 Endoscopic port surgery for intraparenchymal brain tumors.-27Intracranial tumor surgery in the elderly patients.-28 Intracranial hemangiopericytoma: gamma knife surgery.-29 Stereotactic radiosurgery for cerebral metastasis of digestive tract tumors.-30 Malignant brain tumors: role of radioresponsive gene therapy.-Part IV Prognosis.-31 Brain tumors: quality of life.-32 Health related quality of life in patients with high-grage gliomas.-33 Epilepsy  and brain tumors and antiepileptic drugs.-34 Familial caregivers of patients with brain cancer.-35 Pain management following craniotomy.-36 Air transportation of patients with brain tumors. Index.

Textul de pe ultima copertă

The classification of brain tumors is up-dated using magnetic resonance spectroscopy technology. The role of cellular immortality in brain tumors is reviewed. Tumor to tumor metastases are a common occurrence; for example, , brain metastasis from breast cancer, lung cancer, and renal cancer is discussed. Genetic profiling and treatment (including neurosurgery) of such brain cancers are explained. Breast cancer patients treated with certain drugs (e.g., capecitabine and lapatinib can develop CNS tumors. Role of brain tumor suppressor genes (e.g., NRP/B gene) is pointed out. Biomarkers used to diagnose brain malignancies are explained in detail. A number of imaging modalities used for diagnosing and assessing the effectiveness of treatments of brain tumors are presented. The imaging methods discussed include MRI, PET, CT,  MRSi, and SPECT.  Also, is discussed the impact of PET using radiolabeled amino acids on brain tumors.

Caracteristici

Frozen section evaluation of CNS lesions Methods of electrochemotherapy for primary and secondary brain tumors Stereotactic radiosurgery for brain metastasis and ultrasound surgery Epilepsy in brain tumor patients and treatment Pain management following craniotomy and quality of life of patients with brain tumors